These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation. Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991 [TBL] [Abstract][Full Text] [Related]
4. Chronic kidney diseases in long-term survivors after allogeneic hematopoietic stem cell transplantation: monitoring and management guidelines. Abboud I; Peraldi MN; Hingorani S Semin Hematol; 2012 Jan; 49(1):73-82. PubMed ID: 22221787 [TBL] [Abstract][Full Text] [Related]
5. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation. Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632 [TBL] [Abstract][Full Text] [Related]
6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
15. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes. Majhail NS; Parks K; Defor TE; Weisdorf DJ Biol Blood Marrow Transplant; 2006 Oct; 12(10):1038-46. PubMed ID: 17067910 [TBL] [Abstract][Full Text] [Related]
16. Quiz Page May 2017: CKD and Nephrotic Syndrome After Allogeneic Hematopoietic Cell Transplantation. Hogan JJ; Palmer MD; Loren AW; Laskin BL Am J Kidney Dis; 2017 May; 69(5):A10-A13. PubMed ID: 28434525 [No Abstract] [Full Text] [Related]
17. Thrombotic microangiopathy in transplantation and malignancy. Qu L; Kiss JE Semin Thromb Hemost; 2005 Dec; 31(6):691-9. PubMed ID: 16388420 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? Batts ED; Lazarus HM Bone Marrow Transplant; 2007 Oct; 40(8):709-19. PubMed ID: 17603513 [TBL] [Abstract][Full Text] [Related]
19. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258 [TBL] [Abstract][Full Text] [Related]
20. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study. Cohen A; Rovelli A; Merlo DF; van Lint MT; Lanino E; Bresters D; Ceppi M; Bocchini V; Tichelli A; Socié G J Clin Oncol; 2007 Jun; 25(17):2449-54. PubMed ID: 17557958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]